Old Silver VC is an evergreen family-associated fund that makes early stage investments in Biotech, Digital Health, AI, and Material Sciences. We believe that the world’s greatest problems can be solved with innovative science and technology solutions. We seek and support early-stage founders with a vision that can scale from science fiction to new reality.
Artificial Intelligence
Material Sciences
Biotechnology
Digital Health
Biotechnology
Artificial Intelligence
Digital Health
Material Sciences
TEAM
KNOWLEDGE, EXPERIENCE, KINDNESS
Michael Langer
Founding Partner
Michael is the Founding Partner at Old Silver VC, the Head of Search and Evaluation at Pear Therapeutics and a World Economic Forum Global Shaper.
Susan Langer
Venture Partner
Vice President of Business Development at a Cambridge-based cell state start up in stealth mode.
Andrew Emmons, MBA
Operating Advisor
Focuses on early-stage investments in the technology, SaaS, and healthcare industries.
Charlie Lee
Graduate Fellow
M.D. candidate at Harvard-MIT with a focus on early-stage investments in the life sciences and health care space.
Eric Shen
Venture Advisor
Well versed in corporate development and strategic & operational excellence focusing on biotechnology and healthcare.
ADVISORS
David Mou, MBA, MD
Chief Medical Officer at Cerebral & Co-founder / former CMO of Valera Health, a venture-backed digital healthcare company.
Emilia Javorsky, MD, MPH
Physician-Scientist and former Harvard Medical School researcher focused on the development and translation of medical technologies.
Everett Crosland, MS, JD
Life sciences executive, with a proven track record commercializing and scaling complex drugs, drug-device combos, and digital therapeutics.
Giovanni Thermot
Co-founder of ThoughtMetric Inc- a next-generation analytics platform designed to help Mid-Market and SMB eCommerce stores better understand their customers.
Jordan Haviland, MBA
CEO of Brattle Point, LLC, where he focuses on acquiring growing technology and service businesses in scientific and industrial markets.
Livio Valenti, MPP
Sustainability entrepreneur and co-founder of Vaxess Technologies, a biotechnology company reimagining vaccine delivery.
Liz Kwo, MD, MBS, MPH
Deputy Chief Clinical Officer at Anthem & Co-Founder / former CEO of InfiniteMD.
Louis Kang, PhD
Managing Director at AccelR8, Co-Founder at MitoLab, Venture Partner at Korea Technology Bank (KTB) VC
Matthew Lanchantin
Fund advisor specializing in life sciences and biotechnology investments. He brings over 7 years of industry experience as both a bioengineer and business development professional.
Millie Liu
Founding Partner at First Star Ventures, an early-stage venture fund focuses on cutting edge data technologies.
Pavan Choksi
Venture Partner at Arkitekt Ventures & Business Development at Capsule
Rebecca Maynard, LLM, JD
Compliance & Privacy Specialist at Boston Children's Hospital
Rose Wang
Head of CX at NLP startup Forethought.ai, winner of TechCrunch Disrupt and funded by NEA, Village Global, K9 Ventures, etc.
Ryan Coles, MS, PHD
Assistant Professor of Entrepreneurial Management at UConn's School of Business, and the Chief Science Officer at Human Wealth.
Sean Cheng, MP, PHD
Early stage investor in health tech companies and is currently excited about digital therapeutics, remote patient care, novel devices, and disruptive enablers.
Sophie Bai, MBA
Founder and CEO of a biotech company using novel transdermal drug delivery technologies to get large molecules into the skin.
Zack Gow, ME, MS
Data scientist, machine learning engineer, and entrepreneur.
Freddie Martignetti, MBA
Senior Advisor
Investor at Highland Capital Partners, a global leader in early stage consumer and enterprise technology investments.
Robert Langer, Sc. D
Senior Advisor
Dr. Langer is one of 10 Institute professors at MIT (MITs highest honor). He is an expert in the fields of tissue engineering and drug delivery and has founded over 40 startup companies. He is the most cited engineer in history.
OLD SILVER
NEW SILVER
PORTFOLIO
Beta Hatch is developing a platform to mass produce insects as the world’s most sustainable protein.
Sophya is building the metaverse for 'new work'. Forward-looking companies move in to virtual offices in Sophya to build culture and achieve business results.
A clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions.
Creating immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases
A biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases.
A clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases.
An American biotechnology company based in Cambridge, Massachusetts that focus on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.
A global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering with mental health disorders.